JACC. Cardiovascular Interventions, 12, 2035-2046 JACC : cardiovascular interventions JACC: Cardiovascular Interventions, 12(20), 2035-2046. Elsevier Inc. JACC. Cardiovascular interventions, 12(20), 2035-2046. Elsevier Inc. Kim, C H, Koo, B-K, Dehbi, H-M, Lee, J M, Doh, J-H, Nam, C-W, Shin, E-S, Cook, C M, Al-Lamee, R, Petraco, R, Sen, S, Malik, I S, Nijjer, S S, Mejía-Rentería, H, Alegria-Barrero, E, Alghamdi, A, Altman, J, Baptista, S R B, Bhindi, R, Bojara, W, Brugaletta, S, Silva, P C, di Mario, C, Erglis, A, Gerber, R T, Going, O, Härle, T, Hellig, F, Indolfi, C, Janssens, L, Jeremias, A, Kharbanda, R K, Khashaba, A, Kikuta, Y, Krackhardt, F, Laine, M, Lehman, S J, Matsuo, H, Meuwissen, M, Niccoli, G, Piek, J J, Ribichini, F, Samady, H, Sapontis, J, Seto, A H, Sezer, M, Sharp, A S P, Singh, J, Takashima, H, Talwar, S, Tanaka, N, Tang, K, van Belle, E, van Royen, N, Vinhas, H, Vrints, C J, Walters, D, Yokoi, H, Samuels, B, Buller, C, Patel, M R, Serruys, P W, Escaned, J & Davies, J E 2019, ' Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve–Guided Revascularization Strategy ', JACC: Cardiovascular Interventions, vol. 12, no. 20, pp. 2035-2046 . https://doi.org/10.1016/j.jcin.2019.06.035 JACC. Cardiovascular Interventions, 12, 20, pp. 2035-2046 Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação instacron:RCAAP
Journal of the American College of Cardiology, 78(5), 421-433. ELSEVIER SCIENCE INC Journal of The American College of Cardiology, New York : Elsevier Biomedical, 2021, vol. 78, no. 5, p. 421-433 Repositorio Universidad de Santander Universidad de Santander instacron:Universidad de Santander Schwartz, G G, Szarek, M, Bittner, V A, Diaz, R, Goodman, S G, Jukema, J W, Landmesser, U, López-Jaramillo, P, Manvelian, G, Pordy, R, Scemama, M, Sinnaeve, P, White, H D, Gabriel Steg, P, Gabriel Steg, P H, Bhatt, D L, Harrington, R A, Zeiher, A M, Tricoci, P, Roe, M T, Mahaffey, K W, Edelberg, J M, Hanotin, C, Lecorps, G, Moryusef, A, Sasiela, W J, Tamby, J F, Aylward, P E, Drexel, H, Sinnaeve, P, Dilic, M, Lopes, R D, Gotcheva, N N, Prieto, J C, Yong, H, Pećin, I, Reiner, Z, Clemmensen, P, Bang, L E, Hove, J D, Gislason, G, Larsen, J, Johansen, P, Jeppesen, J, Nielsen, P K, Hansen, O, Jensen, S A, Rosenberg, M, Andersen, D & ODYSSEY OUTCOMES Committees and Investigators 2021, ' Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol ', Journal of the American College of Cardiology, vol. 78, no. 5, pp. 421-433 . https://doi.org/10.1016/j.jacc.2021.04.102 Schwartz, G G, Szarek, M, Bittner, V A, Diaz, R, Goodman, S G, Jukema, J W, Landmesser, U, López-Jaramillo, P, Manvelian, G, Pordy, R, Scemama, M, Sinnaeve, P, White, H D, Steg, P G & ODYSSEY OUTCOMES Committees and Investigators 2021, ' Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol ', Journal of the American College of Cardiology, vol. 78, no. 5, pp. 421-433 . https://doi.org/10.1016/j.jacc.2021.04.102 Journal of the American College of Cardiology, vol 78, iss 5